Contact us to learn more about

our Premium Content: News alerts, weekly reports and conference planners

DRUG:

Ontak (denileukin diftitox)

Contact us to learn more about our Premium Content:

News alerts, weekly reports and conference planners

Company:

Dr. Reddy’s, Eisai, TSD Japan

Drug class:

IL-2 stimulant

Related drugs:

›

IL2RA expression	Cutaneous T-cell Lymphoma	IL2RA expression	Cutaneous T-cell Lymphoma	denileukin diftitox Sensitive: A1 - Approval denileukin diftitox Sensitive : A1	denileukin diftitox Sensitive: A1 - Approval denileukin diftitox Sensitive : A1
No biomarker	Peripheral T-cell Lymphoma	No biomarker	Peripheral T-cell Lymphoma	denileukin diftitox Sensitive: A1 - Approval denileukin diftitox Sensitive : A1	denileukin diftitox Sensitive: A1 - Approval denileukin diftitox Sensitive : A1
No biomarker	Cutaneous T-cell Lymphoma	No biomarker	Cutaneous T-cell Lymphoma	denileukin diftitox Sensitive: A1 - Approval denileukin diftitox Sensitive : A1	denileukin diftitox Sensitive: A1 - Approval denileukin diftitox Sensitive : A1
IL2RA expression	Peripheral T-cell Lymphoma	IL2RA expression	Peripheral T-cell Lymphoma	denileukin diftitox Sensitive: C1 - Off-label denileukin diftitox Sensitive : C1	denileukin diftitox Sensitive: C1 - Off-label denileukin diftitox Sensitive : C1